31 search results for ‘*’
11/23/2022 | Angus Stewart | 10 min read
The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world
07/29/2022 | Stephanie Sutton | 8 min read
We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.
07/08/2022 | Maryam Mahdi | 5 min read
Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.
06/14/2022 | 6 min read
How can smart packaging designs help boost medical adherance?
06/08/2022 | Angus Stewart | 5 min read
An inside view on the San Diego company working to bring drug delivering contact lenses to market.
05/11/2022 | Angus Stewart
The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.
04/14/2022 | Lauren Robertson
We sit down with Albert J.R. Heck, Professor at the Science Faculty, Utrecht University, and Scientific Director of the Netherlands Proteomics Centre
04/07/2022
Work by an international team in Japan has found a new and effective way to attack cancer inside the body.
04/01/2022 | Angus Stewart
Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.
03/16/2022 | Angus Stewart
How work on sharks could provide a highly effective weapon against new COVID variants
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
You will benefit from:
Register
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal